Literature DB >> 1347795

Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent.

R A Bessen1, R F Marsh.   

Abstract

Transmissible mink encephalopathy (TME) has been transmitted to Syrian golden hamsters, and two strains of the causative agent, HYPER (HY) and DROWSY (DY), have been identified that have different biological properties. During scrapie, a TME-like disease, an endogenous cellular protein, the prion protein (PrPC), is modified (to PrPSc) and accumulates in the brain. PrPSc is partially resistant to proteases and is claimed to be an essential component of the infectious agent. Purification and analysis of PrP from hamsters infected with the HY and DY TME agent strains revealed differences in properties of PrPTME sedimentation in N-lauroylsarcosine, sensitivity to digestion with proteinase K, and migration in polyacrylamide gels. PrPC and HY PrPTME can be distinguished on the basis of their relative solubilities in detergent and protease sensitivities. PrPTME from DY-infected brain tissue shared solubility characteristics of PrP from both uninfected and HY-infected tissue. Limited protease digestion of PrPTME revealed strain-specific migration patterns upon polyacrylamide gel electrophoresis. Prolonged proteinase K treatment or N-linked deglycosylation of PrPTME did not eliminate such differences but demonstrated the PrPTME from DY-infected brain was more sensitive to protease digestion than HY PrPTME. Antigenic mapping of PrPTME with antibodies raised against synthetic peptides revealed strain-specific differences in immunoreactivity in a region of the amino-terminal end of PrPTME containing amino acid residues 89 to 103. These findings indicate that PrPTME from the two agent strains, although originating from the same host, differ in composition, conformation, or both. We conclude that PrPTME from the HY and DY strains undergo different posttranslational modifications that could explain differences in the biochemical properties of PrPTME from the two sources. Whether these strain-specific posttranslational events are directly responsible for the distinct biological properties of the HY and DY agent strains remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1347795      PMCID: PMC289000     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state.

Authors:  B Caughey; G J Raymond; D Ernst; R E Race
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

2.  Immunological comparison of scrapie-associated fibrils isolated from animals infected with four different scrapie strains.

Authors:  R J Kascsak; R Rubenstein; P A Merz; R I Carp; N K Robakis; H M Wisniewski; H Diringer
Journal:  J Virol       Date:  1986-09       Impact factor: 5.103

3.  Separation and properties of cellular and scrapie prion proteins.

Authors:  R K Meyer; M P McKinley; K A Bowman; M B Braunfeld; R A Barry; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

4.  Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins.

Authors:  R J Kascsak; R Rubenstein; P A Merz; M Tonna-DeMasi; R Fersko; R I Carp; H M Wisniewski; H Diringer
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

5.  Abnormal fibrils from scrapie-infected brain.

Authors:  P A Merz; R A Somerville; H M Wisniewski; K Iqbal
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

6.  Asparagine-linked glycosylation of the scrapie and cellular prion proteins.

Authors:  T Haraguchi; S Fisher; S Olofsson; T Endo; D Groth; A Tarentino; D R Borchelt; D Teplow; L Hood; A Burlingame
Journal:  Arch Biochem Biophys       Date:  1989-10       Impact factor: 4.013

7.  Identification of glycoinositol phospholipid linked and truncated forms of the scrapie prion protein.

Authors:  N Stahl; M A Baldwin; A L Burlingame; S B Prusiner
Journal:  Biochemistry       Date:  1990-09-25       Impact factor: 3.162

8.  Molecular pathology of scrapie-associated fibril protein (PrP) in mouse brain affected by the ME7 strain of scrapie.

Authors:  J Hope; G Multhaup; L J Reekie; R H Kimberlin; K Beyreuther
Journal:  Eur J Biochem       Date:  1988-03-01

9.  Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication.

Authors:  S B Prusiner; M Scott; D Foster; K M Pan; D Groth; C Mirenda; M Torchia; S L Yang; D Serban; G A Carlson
Journal:  Cell       Date:  1990-11-16       Impact factor: 41.582

10.  Primary structure of prion protein may modify scrapie isolate properties.

Authors:  G A Carlson; D Westaway; S J DeArmond; M Peterson-Torchia; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

View more
  175 in total

1.  Affinity-tagged miniprion derivatives spontaneously adopt protease-resistant conformations.

Authors:  S Supattapone; H O Nguyen; T Muramoto; F E Cohen; S J DeArmond; S B Prusiner; M Scott
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Strains of [PSI(+)] are distinguished by their efficiencies of prion-mediated conformational conversion.

Authors:  S M Uptain; G J Sawicki; B Caughey; S Lindquist
Journal:  EMBO J       Date:  2001-11-15       Impact factor: 11.598

Review 3.  The molecular pathology of CJD: old and new variants.

Authors:  G S Jackson; J Collinge
Journal:  Mol Pathol       Date:  2001-12

4.  Strain-specified relative conformational stability of the scrapie prion protein.

Authors:  D Peretz; M R Scott; D Groth; R A Williamson; D R Burton; F E Cohen; S B Prusiner
Journal:  Protein Sci       Date:  2001-04       Impact factor: 6.725

5.  Abrogation of complex glycosylation by swainsonine results in strain- and cell-specific inhibition of prion replication.

Authors:  Shawn Browning; Christopher A Baker; Emery Smith; Sukhvir P Mahal; Maria E Herva; Cheryl A Demczyk; Jiali Li; Charles Weissmann
Journal:  J Biol Chem       Date:  2011-09-19       Impact factor: 5.157

6.  Destabilizing interactions among [PSI(+)] and [PIN(+)] yeast prion variants.

Authors:  Michael E Bradley; Susan W Liebman
Journal:  Genetics       Date:  2003-12       Impact factor: 4.562

7.  Segmental polymorphism in a functional amyloid.

Authors:  Kan-Nian Hu; Ryan P McGlinchey; Reed B Wickner; Robert Tycko
Journal:  Biophys J       Date:  2011-11-01       Impact factor: 4.033

Review 8.  De novo generation of prion strains.

Authors:  David W Colby; Stanley B Prusiner
Journal:  Nat Rev Microbiol       Date:  2011-09-26       Impact factor: 60.633

Review 9.  Prions on the move.

Authors:  Charles Weissmann; Jiali Li; Sukhvir P Mahal; Shawn Browning
Journal:  EMBO Rep       Date:  2011-10-28       Impact factor: 8.807

10.  Report of the Working Group 'Overall Blood Supply Strategy with Regard to Variant Creutzfeldt-Jakob Disease (vCJD)': Statement on the Development and Implementation of Test Systems Suitable for the Screening of Blood Donors for vCJD - Dated September 17, 2008.

Authors: 
Journal:  Transfus Med Hemother       Date:  2009       Impact factor: 3.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.